Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
, 159 (10), 1245-52

Adverse Effects Associated With Selective Serotonin Reuptake Inhibitors and Tricyclic Antidepressants: A Meta-Analysis

Affiliations
Meta-Analysis

Adverse Effects Associated With Selective Serotonin Reuptake Inhibitors and Tricyclic Antidepressants: A Meta-Analysis

E Trindade et al. CMAJ.

Abstract

Background: The use of antidepressant medications and the resulting costs have increased dramatically in recent years, partly because of the introduction of selective serotonin reuptake inhibitors (SSRIs). An assessment of the clinical and economic aspects of SSRIs compared with the older tricyclic antidepressants (TCAs) was initiated to generate information for purchasers of these drugs as well as clinicians. One component of this study was an examination of the adverse effects associated with the use of these drugs.

Methods: Searches of bibliographic databases (for January 1980 through May 1996) and manual scanning of both peer-reviewed publications and other documents were used to identify double-blind, randomized controlled trials involving at least one SSRI and one TCA. For the study of adverse effects, only trials that had at least 20 patients in each trial arm and that reported rates of adverse effects in both arms were retained. In total 84 trials reporting on 18 adverse effects were available. Meta-analyses were undertaken to calculate pooled differences in rates of adverse effects. The question of whether the method of eliciting information from patients about adverse effects made a difference in the findings was also examined. Finally, differences in drop-out rates due to adverse effects were calculated.

Results: The crude rates of occurrence of adverse effects ranged from 4% (palpitations) to 26% (nausea) for SSRIs and from 4% (diarrhea) to 27% (dry mouth) for TCAs. The differences in the rates of adverse effects between the 2 types of drugs ranged from 14% more with SSRIs (for nausea) to 11% more with TCAs (for constipation). The results did not depend on the method of eliciting information from patients. There were no statistically significant differences between drug classes in terms of drop-outs due to adverse effects.

Interpretation: SSRIs and TCAs are both associated with adverse effects, although the key effects differ between the drug classes. Further explanation of the adverse effects and their relation to discontinuation of medication will require better studies involving prospective collection of quality-of-life data.

Comment in

Similar articles

See all similar articles

Cited by 42 PubMed Central articles

See all "Cited by" articles

References

    1. Ann Clin Psychiatry. 1993 Sep;5(3):199-207 - PubMed
    1. Int Clin Psychopharmacol. 1994 Summer;9(2):95-100 - PubMed
    1. BMJ. 1994 Jul 23;309(6949):249-53 - PubMed
    1. Acta Psychiatr Scand. 1994 Jun;89(6):382-9 - PubMed
    1. Psychopharmacology (Berl). 1995 Jun;119(3):277-81 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

Feedback